Pages that link to "Q27666125"

The following pages link to Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2 (Q27666125):

Displaying 36 items.

• Strength and specificity of the CMBA screening platform for bioactive molecules discovery (Q27014820) (← links)
• Protein kinase CK2 and human malignant tumors (Q27026335) (← links)
• Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer (Q27332192) (← links)
• Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells (Q28485087) (← links)
• Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells (Q28547244) (← links)
• Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer (Q33960547) (← links)
• Antitumoral activity of allosteric inhibitors of protein kinase CK2. (Q34106499) (← links)
• The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II. (Q34435367) (← links)
• Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors (Q34665206) (← links)
• Small compounds libraries: a research tool for chemical biology (Q34733011) (← links)
• Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway (Q35205600) (← links)
• Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation (Q35423247) (← links)
• Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition. (Q35783593) (← links)
• Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms (Q35886365) (← links)
• CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target. (Q36263671) (← links)
• Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer (Q36326939) (← links)
• Intercalative DNA binding of the marine anticancer drug variolin B. (Q37554322) (← links)
• Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma (Q37599312) (← links)
• Structural and functional determinants of protein kinase CK2α: facts and open questions. (Q37899062) (← links)
• Protein kinase CK2 inhibitors: a patent review (Q38036342) (← links)
• Casein kinase: the triple meaning of a misnomer (Q38211598) (← links)
• Casein kinases as potential therapeutic targets (Q38632634) (← links)
• Ellipticine derivative induces potent cytostatic effect in acute myeloid leukaemia cells (Q38967701) (← links)
• Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds. (Q39008583) (← links)
• Synthesis and SAR of inhibitors of protein kinase CK2: Novel tricyclic quinoline analogs (Q39428643) (← links)
• Ellipticine induces apoptosis in human endometrial cancer cells: The potential involvement of reactive oxygen species and mitogen-activated protein kinases (Q39489945) (← links)
• Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma (Q39518340) (← links)
• Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2. (Q41416858) (← links)
• Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties (Q42751003) (← links)
• Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling (Q46085978) (← links)
• Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'. (Q47162634) (← links)
• [Search for natural substances with therapeutic activity: Pierre Potier (1934-2006)]. (Q52342499) (← links)
• Hydrosoluble benzo[e]pyridoindolones as potent inhibitors of aurora kinases. (Q53126865) (← links)
• Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management (Q64235651) (← links)
• Role of protein kinase CK2 in antitumor drug resistance (Q91660422) (← links)
• Carbazole scaffolds in cancer therapy: a review from 2012 to 2018 (Q92064512) (← links)